GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Hard to Treat Diseases Inc (OTCPK:HTDS) » Definitions » Other Stockholders Equity

Hard to Treat Diseases (Hard to Treat Diseases) Other Stockholders Equity : $0.00 Mil (As of . 20)


View and export this data going back to . Start your Free Trial

What is Hard to Treat Diseases Other Stockholders Equity?

Hard to Treat Diseases's Other Stockholders Equity for the quarter that ended in . 20 was $0.00 Mil.


Hard to Treat Diseases Other Stockholders Equity Historical Data

The historical data trend for Hard to Treat Diseases's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hard to Treat Diseases Other Stockholders Equity Chart

Hard to Treat Diseases Annual Data
Trend
Other Stockholders Equity

Hard to Treat Diseases Quarterly Data
Other Stockholders Equity

Hard to Treat Diseases Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity


Hard to Treat Diseases Other Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Hard to Treat Diseases's Other Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


Hard to Treat Diseases (Hard to Treat Diseases) Business Description

Traded in Other Exchanges
N/A
Address
2655 Ulmerton Road, No. 338, Clearwater, FL, USA, 33762
Hard to Treat Diseases Inc operates medical and cosmetics company in Europe, and Mainland China. It is s also in the process of developing its own stem cell bank.

Hard to Treat Diseases (Hard to Treat Diseases) Headlines

No Headlines